Tribute Test

ACGT Summit 2026 Marks 25 Years of Progress in Cancer Cell and Gene Therapy

The ACGT Summit 2026 marked the 25th anniversary of the Alliance for Cancer Gene Therapy, celebrating the evolution of cell and gene therapy

Untitled

Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients

A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a

MATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trials

This article presents the MSUD Age-matched Standard Treatment Cohort (MATCH), a prospective natural history study of 11 infants with classic

MATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trials

This article presents the MSUD Age-matched Standard Treatment Cohort (MATCH), a prospective natural history study of 11 infants with classic

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial

Oxford and Moderna receive approval for Phase 1 trial of mRNA vaccine to prevent Lynch syndrome cancers

The INTERCEPT-Lynch trial, a Phase 1 study funded by Moderna and sponsored by the University of Oxford, has received regulatory approval fro